Menu Back to 16th-DIA-Japan-Annual-Meeting-2019

Overview

Join us as at the DIA Japan Annual Meeting 2019, to discuss these topics and the future of healthcare.

Download Program



At DIA, we are here to continue challenging by exerting leadership with a collaboration among industry, government and academia to create a new value in pharmaceutical and medical device development. Needless to say, how to work effectively together is as important as the individual leadership. By maintaining ethics, transparency and fairness, avoiding the conflict of interest and enabling the synergism, a better rational collaboration can be achieved. As a result, our goal is to provide rational medicine with breakthrough innovation to all the current and future people. The 16th DIA Japan Annual Meeting, with a theme of “In Order to Deliver Rational Medicine to all the people in the world,” is a place for discussion, thinking and opinion exchange to contribute to medical environment in the future.

We look forward to welcoming you at Tokyo Big Sight from November 10-12, 2019 for stimulating discussions around promoting better collaboration to drive global health and innovation in this era of medical and scientific transformation.

Program Committee

  • Tatsuya  Kondo, MD, PhD
    Tatsuya Kondo, MD, PhD President
    Medical Excellence Japan, Japan
  • Takashi  Sato, MSc, PMP
    Takashi Sato, MSc, PMP Manager, Resource Management Group, R&D Planning Department
    Kyowa Kirin Co., Ltd., Japan
  • Hiroya  Asou, MD, PhD, MBA
    Hiroya Asou, MD, PhD, MBA Senior Medical Advisor, Global Patient Safety Japan
    Eli Lilly Japan K.K., Japan
  • Noriko  Fujiwara, MS, RN
    Noriko Fujiwara, MS, RN Research Nurse, Project Researcher, Department of Palliative Medicine
    IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Japan
  • Yoshikata  Furuya, MSc
    Yoshikata Furuya, MSc Director, Vaccine Policy, Health Policy
    MSD K.K., Japan
  • Toshinori  Higashi, PhD
    Toshinori Higashi, PhD Planning and Coordination Department Deputy Manager Pharmaceutical Promotion Dep
    CTD Inc., Japan
  • Kazuo  Ichikawa, PhD, PMP
    Kazuo Ichikawa, PhD, PMP Senior Staff Adviser, Group I, Global Project Management Department, R&D Div.
    Daiichi Sankyo Co., Ltd., Japan
  • Katsuhiko  Ichimaru
    Katsuhiko Ichimaru Director for MID-NET project
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Toshiko  Ishibashi, PhD, RN
    Toshiko Ishibashi, PhD, RN Clinical Operation I, JAPAN, Clinical Operation
    Ono Pharmaceutical Co., Ltd., Japan
  • Yoichi M. Ito, PhD
    Yoichi M. Ito, PhD Research Center for Medical and Health Data Science Director
    The Institute of Statistical Mathematics , Japan
  • Miyuki  Kaneko
    Miyuki Kaneko Japan Regulatory Portfolio Lead, Regulatory Affairs
    Pfizer R&D Japan, Japan
  • Yoko  Kazami, RPh, PMP
    Yoko Kazami, RPh, PMP Manager
    Nobelpharma Co., Ltd., Japan
  • Noriatsu  Kono, MPharm
    Noriatsu Kono, MPharm Managing Director, Department of Innovative Drug Discovery and Development
    Japan Agency for Medical Research and Development (AMED), Japan
  • Arisa  Maeda
    Arisa Maeda CMC Regulatory Affairs, Regulatory Affairs Area, Japan Development
    MSD K.K., Japan
  • Noriaki  Nagao, MPharm, PMP
    Noriaki Nagao, MPharm, PMP Director, Quality Control Team Leader, Clinical Development Dept.
    Japan Tobacco Inc., Japan
  • Motohide  Nishi, MBA
    Motohide Nishi, MBA Vice President, APAC Professional Services and Customer Care
    Medidata Solutions K.K., Japan
  • Minori  Niso
    Minori Niso Acute Care Diagnostics Product Manager, Instrumentation Laboratory
    I.L. Japan Co., Ltd., Japan
  • Hiromi  Okabe, PhD
    Hiromi Okabe, PhD Manager, Global Regulatory Management Group, New Drug Regulatory Affairs Dept.
    Daiichi Sankyo Co., Ltd., Japan
  • Hiroshi  Sakaguchi
    Hiroshi Sakaguchi Reviewer, Office of New Drug II
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Norio  Shimazaki
    Norio Shimazaki Senior Manager, Regional Clinical Operations Japan, Korea and Taiwan
    Bristol-Myers Squibb K.K., Japan
  • Mikiko  Shitara
    Mikiko Shitara Manager, Labeling Group, RA Management, RA, Development & Medical Affairs Div.
    GlaxoSmithKline K.K., Japan
  • Kuniko  Shoji
    Kuniko Shoji Project Researcher
    Japan Society For the Promotion of Machine Industry, Japan
  • Keiko  Tsumori
    Keiko Tsumori Associate Director, Medical Writing, Regulatory Affairs Area, Japan Development
    MSD K.K., Japan
  • Tadashi  Urashima, PhD
    Tadashi Urashima, PhD Manager (Strategy Deployment and Digital Practices), MA Excellence Dept.
    GlaxoSmithKline K.K., Japan
  • Manami  Yoshida, DVM
    Manami Yoshida, DVM Manager, Global Medical Affairs
    Shionogi & Co., Ltd., Japan
  • Koichiro  Yuji, MD, PhD, FACP
    Koichiro Yuji, MD, PhD, FACP Project Associate Professor, The Institute of Medical Science
    The University of Tokyo, Japan
  • Kazuhiro  Kanmuri, PhD
    Kazuhiro Kanmuri, PhD Head, Clinical Development
    Ascent Therapeutics, Japan
  • Kazumichi  Kobayashi, RPh
    Kazumichi Kobayashi, RPh Senior Vice President, Business Development and Planning
    Otsuka Holdings Co., Ltd., Japan
  • Junichi  Nishino, MSc, RPh
    Junichi Nishino, MSc, RPh Director, Medical Regulatory Affairs Department
    Otsuka Pharmaceutical Co., Ltd., Japan
  • Hironobu  Saito, PhD
    Hironobu Saito, PhD Corporate Officer /Vice President, Oncology Clinical Development Dept., R&D Div.
    Daiichi Sankyo Co., Ltd., Japan
  • Junko  Sato, PhD
    Junko Sato, PhD Director, Office of International Programs
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Eri  Sekine
    Eri Sekine Department Head, Trial Monitoring, Japan Development, Global Development Ops.
    Novartis Pharma K.K., Japan
  • Atsushi  Tsukamoto, PhD, MSc
    Atsushi Tsukamoto, PhD, MSc Vice President, New Drug Regulatory Affairs
    Daiichi Sankyo Co., Ltd., Japan
Load More